Naturally Splendid Enterprises Ltd V.NSP.H

RE:RE:FDA given the go ahead to start trial

[dontknowmuch]

broke wrote: Looks like it might already be registered, as I am not sure if this magazine is USA based or Canadian.

Have a look at the Covid-19 Too soon to Tell section of the top 200 candidates in the following catagories,

COVID-19: 200 Candidates and Counting

To navigate through the >200 potential therapeutic and vaccine options for COVID-19, GEN has grouped the candidates into four broad categories based on their developmental and (where applicable) clinical progress:

 

 FRONT RUNNER – the most promising therapeutics/vaccines based on clinical progress, favorable data or both.

 DEFINITELY MAYBE – earlier phases with promising partners, or more advanced candidates in development that have generated uneven data.

 KEEPING AN EYE ON… – interesting technology, attracting notable partners, or both, but preliminary data.

 TOO SOON TO TELL – longshots pending additional experimental and/or clinical data.

GEN has also tagged the most common treatment types:

ANTIVIRAL
VAX
ANTIBODY
RNA

the pages load very slow but links do work.

Have a look.
https://www.genengnews.com/about-gen/

https://www.genengnews.com/covid-19-candidates/

https://www.genengnews.com/covid-19-candidates/biologic-pharmamedical-and-naturally-splendid-enterprises-cavaltinib/

It would appear they are in the top 200 with US based companies.

Long shot or not, it is a contender. most likely because it just got registered.

Broke out

Hey “broke”,

Great DD! Thanks for posting! :<)

Links loaded fine.

Definitely agree:  “Long shot or not, it is a contender.  Most likely because it just got registered.”

*****

Be safe!

*****

“Living in the sunshine”
Always DYODD
DKM